{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:51:59Z","timestamp":1776091919264,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-022-00709-y","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T17:24:27Z","timestamp":1653067467000},"page":"506-510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rituximab-induced serum sickness in a girl with nephrotic syndrome"],"prefix":"10.1007","volume":"11","author":[{"given":"Yuka","family":"Kimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Kiyota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayo","family":"Ikeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9289-478X","authenticated-orcid":false,"given":"Kazuhito","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"issue":"9950","key":"709_CR1","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/s0140-6736(14)60541-9","volume":"384","author":"K Iijima","year":"2014","unstructured":"Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, et al. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2014;384(9950):1273\u201381. https:\/\/doi.org\/10.1016\/s0140-6736(14)60541-9.","journal-title":"Lancet"},{"key":"709_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/srep46036","volume":"7","author":"T Takura","year":"2017","unstructured":"Takura T, Takei T, Nitta K. Cost-effectiveness of administering rituximab for steroid-dependent nephrotic syndrome and frequently relapsing nephrotic syndrome: a preliminary study in Japan. Sci Rep. 2017;7: 46036. https:\/\/doi.org\/10.1038\/srep46036.","journal-title":"Sci Rep"},{"issue":"3","key":"709_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.semarthrit.2015.06.014","volume":"45","author":"P Karmacharya","year":"2015","unstructured":"Karmacharya P, Poudel DR, Pathak R, Donato AA, Ghimire S, Giri S, et al. Rituximab-induced serum sickness: a systematic review. Semin Arthritis Rheum. 2015;45(3):334\u201340. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.014.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"709_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/01.rhu.0000262585.18582.1e","volume":"13","author":"E Finger","year":"2007","unstructured":"Finger E, Scheinberg M. Development of serum sickness-like symptoms after rituximab infusion in two patients with severe hypergammaglobulinemia. J Clin Rheumatol. 2007;13(2):94\u20135. https:\/\/doi.org\/10.1097\/01.rhu.0000262585.18582.1e.","journal-title":"J Clin Rheumatol"},{"key":"709_CR5","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/1529-0131(200107)44:7<1717::AID-ART299>3.0.CO;2-C","volume":"44","author":"CA D\u2019Arcy","year":"2001","unstructured":"D\u2019Arcy CA, Mannik M, MD University of Washington Seattle, WA. Serum sickness secondary to treatment with the murine-human chimeric antibody IDEC-C2B8 (rituximab). Arthritis Rheum. 2001;44:1717\u20138. https:\/\/doi.org\/10.1002\/1529-0131(200107)44:7%3c1717::AID-ART299%3e3.0.CO;2-C.","journal-title":"Arthritis Rheum"},{"issue":"22","key":"709_CR6","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/nejm198411293112204","volume":"311","author":"TJ Lawley","year":"1984","unstructured":"Lawley TJ, Bielory L, Gascon P, Yancey KB, Young NS, Frank MM. A prospective clinical and immunologic analysis of patients with serum sickness. N Engl J Med. 1984;311(22):1407\u201313. https:\/\/doi.org\/10.1056\/nejm198411293112204.","journal-title":"N Engl J Med"},{"issue":"1","key":"709_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00005792-198801000-00003","volume":"67","author":"L Bielory","year":"1988","unstructured":"Bielory L, Gascon P, Lawley TJ, Young NS, Frank MM. Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure. Medicine (Baltimore). 1988;67(1):40\u201357.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"709_CR8","first-page":"586","volume":"52","author":"GH Neild","year":"1983","unstructured":"Neild GH, Ivory K, Hiramatsu M, Williams DG. Cyclosporin A inhibits acute serum sickness nephritis in rabbits. Clin Exp Immunol. 1983;52(3):586\u201394.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"709_CR9","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1634\/theoncologist.2008-0012","volume":"13","author":"CH Chung","year":"2008","unstructured":"Chung CH. Managing premedications and the risk for reactions to infusional monoclonal antibody therapy. Oncologist. 2008;13(6):725\u201332. https:\/\/doi.org\/10.1634\/theoncologist.2008-0012.","journal-title":"Oncologist"},{"issue":"3","key":"709_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s12185-009-0269-6","volume":"89","author":"S Goto","year":"2009","unstructured":"Goto S, Goto H, Tanoshima R, Kato H, Takahashi H, Sekiguchi O, et al. Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura. Int J Hematol. 2009;89(3):305\u20139. https:\/\/doi.org\/10.1007\/s12185-009-0269-6.","journal-title":"Int J Hematol"},{"key":"709_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejim.2019.06.009","volume":"67","author":"G Bayer","year":"2019","unstructured":"Bayer G, Agier MS, Lioger B, Lepelley M, Zenut M, Lanoue MC, et al. Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: a French nationwide study. Eur J Intern Med. 2019;67:59\u201364. https:\/\/doi.org\/10.1016\/j.ejim.2019.06.009.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"709_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s13730-017-0297-7","volume":"7","author":"R Maeda","year":"2018","unstructured":"Maeda R, Kawasaki Y, Ohara S, Suyama K, Hosoya M. Serum sickness with refractory nephrotic syndrome following treatment with rituximab. CEN Case Rep. 2018;7(1):69\u201372. https:\/\/doi.org\/10.1007\/s13730-017-0297-7.","journal-title":"CEN Case Rep"},{"issue":"5","key":"709_CR13","doi-asserted-by":"publisher","first-page":"884","DOI":"10.24953\/turkjped.2020.05.025","volume":"62","author":"MT Bayram","year":"2020","unstructured":"Bayram MT, Soylu A, Kavukcu S. Rituximab-induced serum sickness and anaphylaxis in a child with nephrotic syndrome. Turk J Pediatr. 2020;62(5):884\u20138. https:\/\/doi.org\/10.24953\/turkjped.2020.05.025.","journal-title":"Turk J Pediatr"},{"issue":"1","key":"709_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/ped.14738","volume":"64","author":"H Majima","year":"2022","unstructured":"Majima H, Kasahara K, Gotoh Y. Rituximab-induced serum sickness with idiopathic nephrotic syndrome in a child. Pediatr Int. 2022;64(1): e14738. https:\/\/doi.org\/10.1111\/ped.14738.","journal-title":"Pediatr Int"},{"issue":"2","key":"709_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13730-020-00449-x","volume":"9","author":"M Nakamura","year":"2020","unstructured":"Nakamura M, Kanda S, Yoshioka Y, Takahashi C, Owada K, Kajiho Y, et al. Rituximab-induced serum sickness in a 6-year-old boy with steroid-dependent nephrotic syndrome. CEN Case Rep. 2020;9(2):173\u20136. https:\/\/doi.org\/10.1007\/s13730-020-00449-x.","journal-title":"CEN Case Rep"},{"issue":"4","key":"709_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s13730-020-00492-8","volume":"9","author":"M Sato","year":"2020","unstructured":"Sato M, Yamada M, Nakajima M, Miyama Y, Kitayama H. The case of Kawasaki disease after rituximab infusion triggered by human anti-chimeric antibodies. CEN Case Rep. 2020;9(4):392\u20134. https:\/\/doi.org\/10.1007\/s13730-020-00492-8.","journal-title":"CEN Case Rep"},{"key":"709_CR17","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3389\/fimmu.2019.01156","volume":"10","author":"S Menikou","year":"2019","unstructured":"Menikou S, Langford PR, Levin M. Kawasaki disease: the role of immune complexes revisited. Front Immunol. 2019;10:1156. https:\/\/doi.org\/10.3389\/fimmu.2019.01156.","journal-title":"Front Immunol"},{"issue":"5","key":"709_CR18","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s10067-020-04996-7","volume":"39","author":"L Bergantini","year":"2020","unstructured":"Bergantini L, d\u2019Alessandro M, Cameli P, Vietri L, Vagaggini C, Perrone A, et al. Effects of rituximab therapy on B cell differentiation and depletion. Clin Rheumatol. 2020;39(5):1415\u201321. https:\/\/doi.org\/10.1007\/s10067-020-04996-7.","journal-title":"Clin Rheumatol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00709-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-022-00709-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00709-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T20:47:02Z","timestamp":1667335622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-022-00709-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["709"],"URL":"https:\/\/doi.org\/10.1007\/s13730-022-00709-y","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"3 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the parents of the patient included in this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}